<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01021514</url>
  </required_header>
  <id_info>
    <org_study_id>PET(RAGE)</org_study_id>
    <nct_id>NCT01021514</nct_id>
  </id_info>
  <brief_title>Association Between Arterial Wall Uptake of Fluorodeoxyglucose on PET Imaging and sRAGE</brief_title>
  <official_title>Association Between Arterial Wall Uptake of Fluorodeoxyglucose on PET Imaging and sRAGE</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Korea University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Korea University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Arteriosclerosis is a dynamic inflammatory disorder. Recently, FDG-PET CT is emerging
      diagnostic tool of non-invasive technique to detect vulnerable atherosclerotic plaque. And
      there are arising evidence that sRAGE(soluble Receptor for Advanced glycation End Product) is
      correlated with metabolic risk. So the investigators will investigate association between
      sRAGE and FDG-PET uptake in large artery in healthy patient.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>January 2009</start_date>
  <completion_date type="Actual">November 2010</completion_date>
  <primary_completion_date type="Actual">August 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">82</enrollment>
  <condition>sRAGE Level</condition>
  <condition>SUV and TBR Levels in FDG PET</condition>
  <arm_group>
    <arm_group_label>Type 2 DM, Healthy control</arm_group_label>
    <description>Type 2 DM patients are treating in the Diabetic Clinic of Korea university Guro hospital, and their age- and sex-matched healthy controls are underwent a routine health checkup at Korea university Guro hospital.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Type 2 DM, Heatlhy control</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        type 2 DM diagnoed according to critereia of American Diabetes Asociation.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Clinical diagnosis od type 2 DM

        Exclusion Criteria:

          -  Type 1 DM

          -  Gestational Diabetes

          -  Severe Liver or Renal disease

          -  Diagnosis of cancer

          -  Trauma

          -  Acute infection or inflammatory disease

          -  Acute vasculitis or history of vasculitis

          -  Pregnant or Lactating women

          -  Dyslipidemia(active state)

          -  Cardiovascular disease or history of CVD

          -  Chronic obstructive pulmonary disease

          -  Any patient by judge of investigator
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kyoungmook Choi, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Korea University Guro Hospital</affiliation>
  </overall_official>
  <verification_date>April 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 27, 2009</study_first_submitted>
  <study_first_submitted_qc>November 27, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 30, 2009</study_first_posted>
  <last_update_submitted>April 5, 2011</last_update_submitted>
  <last_update_submitted_qc>April 5, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 6, 2011</last_update_posted>
  <responsible_party>
    <name_title>Korea University Guro Hopital Endocrinology department</name_title>
    <organization>Korea University Guro Hospital</organization>
  </responsible_party>
  <keyword>sRAGE</keyword>
  <keyword>SUV</keyword>
  <keyword>TBR</keyword>
  <keyword>FDG PET CT</keyword>
  <keyword>Type 2 DM</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fluorodeoxyglucose F18</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

